123 related articles for article (PubMed ID: 34353021)
1. AND-Logic Strategy for Accurate Analysis of Alzheimer's Disease via Fluorescent Probe Lighted Up by Two Specific Biomarkers.
Zhang P; Fu C; Liu H; Guo X; Zhang Q; Gao J; Chen W; Yuan W; Ding C
Anal Chem; 2021 Aug; 93(32):11337-11345. PubMed ID: 34353021
[TBL] [Abstract][Full Text] [Related]
2. Dual-Mode Ratiometric Electrochemical and Turn-On Fluorescent Detection of Butyrylcholinesterase Utilizing a Single Probe for the Diagnosis of Alzheimer's Disease.
Dong H; Zhao L; Wang T; Chen Y; Hao W; Zhang Z; Hao Y; Zhang C; Wei X; Zhang Y; Zhou Y; Xu M
Anal Chem; 2023 May; 95(21):8340-8347. PubMed ID: 37192372
[TBL] [Abstract][Full Text] [Related]
3. Developing a Two-Photon "AND" Logic Probe and Its Application in Alzheimer's Disease Differentiation.
Guo J; Sun J; Liu D; Liu J; Gui L; Luo M; Kong D; Wusiman S; Yang C; Liu T; Yuan Z; Li R
Anal Chem; 2023 Nov; 95(46):16868-16876. PubMed ID: 37947381
[TBL] [Abstract][Full Text] [Related]
4. Thiol-ene click reaction-induced fluorescence enhancement by altering the radiative rate for assaying butyrylcholinesterase activity.
Chen G; Feng H; Xi W; Xu J; Pan S; Qian Z
Analyst; 2019 Jan; 144(2):559-566. PubMed ID: 30417195
[TBL] [Abstract][Full Text] [Related]
5. Near-infrared ratiometric fluorescent strategy for butyrylcholinesterase activity and its application in the detection of pesticide residue in food samples and biological imaging.
Yuan W; Wan C; Zhang J; Li Q; Zhang P; Zheng K; Zhang Q; Ding C
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Sep; 297():122719. PubMed ID: 37043836
[TBL] [Abstract][Full Text] [Related]
6. Rational design of a near-infrared fluorescence probe for highly selective sensing butyrylcholinesterase (BChE) and its bioimaging applications in living cell.
Ma J; Lu X; Zhai H; Li Q; Qiao L; Guo Y
Talanta; 2020 Nov; 219():121278. PubMed ID: 32887168
[TBL] [Abstract][Full Text] [Related]
7. Ratiometric imaging of butyrylcholinesterase activity in mice with nonalcoholic fatty liver using an AIE-based fluorescent probe.
Xiang C; Xiang J; Yang X; Li C; Zhou L; Jiang D; Peng Y; Xu Z; Deng G; Zhu B; Zhang P; Cai L; Gong P
J Mater Chem B; 2022 Jun; 10(22):4254-4260. PubMed ID: 35583194
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for Live-Cell and In Vivo Imaging.
Liu SY; Xiong H; Yang JQ; Yang SH; Li Y; Yang WC; Yang GF
ACS Sens; 2018 Oct; 3(10):2118-2128. PubMed ID: 30203965
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent Determination of Butyrylcholinesterase Activity and Its Application in Biological Imaging and Pesticide Residue Detection.
Zhang Q; Fu C; Guo X; Gao J; Zhang P; Ding C
ACS Sens; 2021 Mar; 6(3):1138-1146. PubMed ID: 33503372
[TBL] [Abstract][Full Text] [Related]
10. Near-infrared mito-specific fluorescent probe for ratiometric detection and imaging of alkaline phosphatase activity with high sensitivity.
Zhang Q; Li S; Fu C; Xiao Y; Zhang P; Ding C
J Mater Chem B; 2019 Jan; 7(3):443-450. PubMed ID: 32254731
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Alzheimer's Disease and
Yang Y; Zhang L; Wang J; Cao Y; Li S; Qin W; Liu Y
Anal Chem; 2022 Oct; 94(39):13498-13506. PubMed ID: 36121878
[TBL] [Abstract][Full Text] [Related]
12. Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies?
Josviak ND; Batistela MS; Souza RKM; Wegner NR; Bono GF; Sulzbach CD; Simão-Silva DP; Piovezan MR; Souza RLR; Furtado-Alle L
Int J Neurosci; 2017 Dec; 127(12):1082-1086. PubMed ID: 28504037
[TBL] [Abstract][Full Text] [Related]
13. A simple approach to quantitative determination of soluble amyloid-β peptides using a ratiometric fluorescence probe.
Li C; Yang L; Han Y; Wang X
Biosens Bioelectron; 2019 Oct; 142():111518. PubMed ID: 31326861
[TBL] [Abstract][Full Text] [Related]
14. Carbon dots sensitized lanthanide infinite coordination polymer nanoparticles: Towards ratiometric fluorescent sensing of cerebrospinal Aβ monomer as a biomarker for Alzheimer's disease.
Liu C; Lu D; You X; Shi G; Deng J; Zhou T
Anal Chim Acta; 2020 Apr; 1105():147-154. PubMed ID: 32138913
[TBL] [Abstract][Full Text] [Related]
15. Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes.
Pajk S; Knez D; Košak U; Zorović M; Brazzolotto X; Coquelle N; Nachon F; Colletier JP; Živin M; Stojan J; Gobec S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):498-505. PubMed ID: 31914836
[TBL] [Abstract][Full Text] [Related]
16. A ratiometric fluorescence probe based on carbon dots for discriminative and highly sensitive detection of acetylcholinesterase and butyrylcholinesterase in human whole blood.
Xu X; Cen Y; Xu G; Wei F; Shi M; Hu Q
Biosens Bioelectron; 2019 Apr; 131():232-236. PubMed ID: 30849722
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a butyrylcholinesterase-specific probe via a structure-based design strategy.
Yang SH; Sun Q; Xiong H; Liu SY; Moosavi B; Yang WC; Yang GF
Chem Commun (Camb); 2017 Apr; 53(28):3952-3955. PubMed ID: 28322391
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.
Macdonald IR; Maxwell SP; Reid GA; Cash MK; DeBay DR; Darvesh S
J Alzheimers Dis; 2017; 58(2):491-505. PubMed ID: 28453492
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence-Guided Cancer Diagnosis and Surgery by a Zero Cross-Talk Ratiometric Near-Infrared γ-Glutamyltranspeptidase Fluorescent Probe.
Ou-Yang J; Li Y; Jiang WL; He SY; Liu HW; Li CY
Anal Chem; 2019 Jan; 91(1):1056-1063. PubMed ID: 30539637
[TBL] [Abstract][Full Text] [Related]
20. Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer's disease in a Southern Brazilian population.
Bono GF; Simão-Silva DP; Batistela MS; Josviak ND; Dias PF; Nascimento GA; Souza RL; Piovezan MR; Souza RK; Furtado-Alle L
Neurochem Int; 2015 Feb; 81():57-62. PubMed ID: 25624079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
